Home The Active Ingredient Matrix Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid)

Formulation Intelligence

Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid).

AKBA is a potent pentacyclic triterpenoid that selectively inhibits 5-lipoxygenase (5-LOX), thereby suppressing the biosynthesis of pro-inflammatory leukotrienes in chronic inflammatory conditions like osteoarthritis and asthma.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

11386458

Molecular Weight

498.7 g/mol

XLogP3 (Lipophilicity)

8.3

IUPAC Name

(3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-acetyloxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picene-4-carboxylic acid

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Curcumin for synergistic inhibition of the NF-κB pathway
  • Glucosamine for enhanced chondroprotective effects in joint tissue

Biological Formulation Enhancers

  • Piperine for inhibition of glucuronidation and increased systemic bioavailability
  • Lecithin for the formation of phytosomes to improve lipophilic absorption

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid) across standard consumer modalities.

💊 Standard Capsules

The high lipophilicity of AKBA requires the inclusion of surfactants or oil-based carriers to prevent poor dissolution and erratic absorption from dry powder matrices.

🍬 Gummy & Pectin Formats

AKBA's hydrophobic nature and distinct resinous odor pose significant challenges for achieving a homogenous dispersion and palatable flavor profile in aqueous pectin bases.

🔬 Thin-Film Oral Strips

The high therapeutic dose required for AKBA often exceeds the 20-30mg payload capacity of standard thin-film polymer matrices, limiting its application in this format.

For Brand Founders

Formulate with Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid)

Ready to launch a product featuring Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid) Bioavailability

Need absolute proof that your Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid) Degradation Testing

Is your Boswellia Serrata (Acetyl-11-keto-beta-boswellic acid) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation